Tang Caixi相关文献与解析，生知库 | 链接生命科学的每一步

GPX2 inhibition enhances antitumor efficacy of lenvatinib via promoting immunogenic cell death in hepatocellular carcinoma.

GPX2 抑制通过促进肝细胞癌中的免疫原性细胞死亡来增强乐伐替尼的抗肿瘤疗效

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-025-06468-5

Tan Yingzheng, Yang Lei, Xu Tao, Wang Qingbin, Huang Meiyuan, Zhao Zhijian, Chen Xun, Tang Caixi, Tan Wenliang

CD2AP is a disulfidptosis modulator and prognostic biomarker in hepatocellular carcinoma.

CD2AP 是肝细胞癌中的二硫键凋亡调节因子和预后生物标志物。

期刊:Clinical and Experimental Medicine

影响因子:3.5

doi:10.1007/s10238-025-01917-3

Tan Yingzheng, Yang Lei, Wang Qingbin, Huang Meiyuan, Yi Bo, Wan Jian, Xu Tao, Zhao Zhijian, Tang Caixi, Xie Yang, Chen Xun, Tan Wenliang

Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis

预测肝细胞癌免疫治疗中 CAF 相关基因及药物敏感性：一项多数据库分析

期刊:Genes and Immunity

影响因子:4.5

doi:10.1038/s41435-024-00252-z

Yao, Yi; Yang, KaiQing; Wang, Qiang; Zhu, Zeming; Li, Sheng; Li, Bin; Feng, Bin; Tang, Caixi

Macrophage migration inhibitory factor is an early marker of severe acute pancreatitis based on the revised Atlanta classification.

根据修订后的亚特兰大分类，巨噬细胞迁移抑制因子是重症急性胰腺炎的早期标志物

期刊:BMC Gastroenterology

影响因子:2.6

doi:10.1186/s12876-020-01598-0

Shen Dingcheng, Tang Caixi, Zhu Shuai, Huang Gengwen

Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on TNF Family Members

基于TNF家族成员的胰腺癌预后和免疫通路分子分析

期刊:Journal of Oncology

影响因子:

doi:10.1155/2021/2676996

Zhu, Zemin; Tang, Caixi; Xu, Tao; Zhao, Zhijian

Definition of a novel vascular invasion-associated multi-gene signature for predicting survival in patients with hepatocellular carcinoma

定义一种新型血管侵袭相关多基因特征，用于预测肝细胞癌患者的生存期

期刊:Oncology Letters

影响因子:2.2

doi:10.3892/ol.2019.11072

Yi, Bo; Tang, Caixi; Tao, Yin; Zhao, Zhijian

The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials

血管加压素V2受体拮抗剂治疗伴有腹水的肝硬化患者：一项随机对照试验的荟萃分析

期刊:BMC Gastroenterology

影响因子:2.6

doi:10.1186/s12876-015-0297-z

Yan, Long; Xie, Feng; Lu, Jiongjiong; Ni, Qingqiang; Shi, Changying; Tang, Caixi; Yang, Jiamei

ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis.

ESM1 通过三油酸酯合成驱动癌症血管生成和贝伐单抗耐药性。

Hypertriglyceridemic acute pancreatitis: a bibliometric analysis from 2002 to 2023

高甘油三酯血症性急性胰腺炎：2002年至2023年的文献计量分析

GPX2 inhibition enhances antitumor efficacy of lenvatinib via promoting immunogenic cell death in hepatocellular carcinoma.

GPX2 抑制通过促进肝细胞癌中的免疫原性细胞死亡来增强乐伐替尼的抗肿瘤疗效

CD2AP is a disulfidptosis modulator and prognostic biomarker in hepatocellular carcinoma.

CD2AP 是肝细胞癌中的二硫键凋亡调节因子和预后生物标志物。

Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis

预测肝细胞癌免疫治疗中 CAF 相关基因及药物敏感性：一项多数据库分析

Macrophage migration inhibitory factor is an early marker of severe acute pancreatitis based on the revised Atlanta classification.

根据修订后的亚特兰大分类，巨噬细胞迁移抑制因子是重症急性胰腺炎的早期标志物

Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on TNF Family Members

基于TNF家族成员的胰腺癌预后和免疫通路分子分析

Definition of a novel vascular invasion-associated multi-gene signature for predicting survival in patients with hepatocellular carcinoma

定义一种新型血管侵袭相关多基因特征，用于预测肝细胞癌患者的生存期

The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials

血管加压素V2受体拮抗剂治疗伴有腹水的肝硬化患者：一项随机对照试验的荟萃分析